Skip to content

Genetic analysis for EGFR gene mutations (using a nucleic acid probe)

Published: August 9, 2026Updated: August 16, 2026

This test checks for specific changes (mutations) in the EGFR gene, which may be linked to certain types of cancer, including non-small cell lung cancer.

Quick summary

["Helps determine if targeted cancer treatments may be effective for your condition."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
87377-8
Short code
EC stx2 gene Islt Ql NAA+probe
Synonyms
EC stx2 gene Islt Ql NAA+probe
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
probe-amp-tar
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Is Done

Your doctor may recommend this test if you have been diagnosed with a type of cancer that is suspected to be driven by EGFR gene mutations, such as non-small cell lung cancer. It helps guide treatment decisions by identifying whether certain targeted therapies could be beneficial.

How the Test Works

A small sample of your tumor tissue or blood is collected and analyzed using a specialized nucleic acid probe to detect specific mutations in the EGFR gene. This process identifies genetic variations that may respond to targeted medications.

Sample Collection and Preparation

The test requires either a tissue sample (such as a biopsy) or blood sample, depending on the type of cancer and clinical guidelines. Your healthcare provider will explain the process and ensure it is done safely and comfortably.

What to Expect Before the Test

No special preparation is usually needed for this test, but you may be asked to avoid certain medications or fasting, depending on the sample type. Follow your healthcare provider’s instructions closely.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Positive results for EGFR mutations may indicate that certain targeted therapies (such as tyrosine kinase inhibitors) could be effective in treating your cancer. This information helps tailor treatment plans to improve outcomes and reduce side effects. Negative results suggest other treatments or approaches may be more appropriate.

Short name

EGFR Mutation Test

Frequently asked questions

What does a positive result mean?
A positive result means that your cancer may have specific genetic changes linked to EGFR mutations. This could mean you may benefit from certain targeted cancer treatments that are designed to target these mutations.
What if my test result is negative?
A negative result means that the cancer in your sample does not have the specific EGFR mutations being tested for. Your doctor will work with you to determine the best course of treatment based on other factors, such as cancer type, stage, and other genetic tests.
How long will it take to get my results?
Results from this test typically take several days to a couple of weeks, depending on the laboratory and complexity of the analysis. Your healthcare provider will contact you once the results are ready.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy